SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Tilak Ventures Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

503663

INE026L01022

1.7400421

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.4

156.44

EPS(TTM)

Face Value()

Div & Yield %

0.05

Back

simplex papers ltd

Shukra Pharmaceuticals standalone net profit rises 340.74% in the September 2025 quarter

Nov 14,2025

Net profit of Shukra Pharmaceuticals rose 340.74% to Rs 2.38 crore in the quarter ended September 2025 as against Rs 0.54 crore during the previous quarter ended September 2024. Sales rose 5.76% to Rs 5.88 crore in the quarter ended September 2025 as against Rs 5.56 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.88	5.56	6
OPM %	-6.97	12.05	-
PBDT	1.01	1.58	-36
PBT	0.20	0.88	-77
NP	2.38	0.54	341

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,604.22 -63.41 (-0.59%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)